13 May, 2025

Comend and Odylia Partner to Advance Rare Disease Drug Development with Innovative Patient-Driven Platform

05 May, 2025

Odylia Therapeutics Announces New Pipeline Project: A Gene Replacement Therapy for NPHP1 Retinal Dystrophy

Odylia Therapeutics Welcomes Joy Cavagnaro to Board of Directors

Odylia Therapeutics is pleased to announce the appointment of Joy Cavagnaro to its Board of Directors....

12 March, 2025